Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Claire, Gaunt"'
Autor:
Paul Nankivell, Piers Gaunt, Claire Gaunt, Julia Sissons, Evaggelia Liaskou, Yolande Jefferson, Tessa Fulton-Lieuw, Saloni Mittal, Hisham Mehanna, PETNECK2 Research Team
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Approximately 40% of treated head and neck cancer (HNC) patients develop recurrence. The risk of recurrence declines with time from treatment. Current guidelines recommend clinical follow-up every two months for the first two year
Externí odkaz:
https://doaj.org/article/907199b2529a4794a0bf52c1030cc1ff
Autor:
Amit Patel, Kristian Brock, Daniel Slade, Claire Gaunt, Anthony Kong, Hisham Mehanna, Lucinda Billingham, Piers Gaunt
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background In this article we describe the methodology of the time-to-event continual reassessment method in the presence of partial orders (PO-TITE-CRM) and the process of implementing this trial design into a phase I trial in head and neck
Externí odkaz:
https://doaj.org/article/482169edd81b4cb08d5b3a47c93c2213
Autor:
Paul Nankivell, Piers Gaunt, Claire Gaunt, Julia Sissons, Evaggelia Liaskou, Yolande Jefferson, Tessa Fulton-Lieuw, Saloni Mittal, Hisham Mehanna, PETNECK2 Research Team
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/e20a71dcd14e4932945edc0364d459d6
Autor:
Sally Wheelwright, Lucy Matthews, Valerie Jenkins, Shirley May, Daniel Rea, Pat Fairbrother, Claire Gaunt, Jennie Young, Sarah Pirrie, Matthew G. Wallis, Lesley Fallowfield, on behalf of the LORIS Trial Management Group
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background The LOw RISk DCIS (LORIS) study was set up to compare conventional surgical treatment with active monitoring in women with ductal carcinoma in situ (DCIS). Recruitment to trials with a surveillance arm is known to be challenging,
Externí odkaz:
https://doaj.org/article/503fbba1f83546d5b5e97ab96d86990c
Autor:
Jennifer Pascoe, Aimee Jackson, Charlotte Gaskell, Claire Gaunt, Joyce Thompson, Lucinda Billingham, Neil Steven
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Cancer cachexia causes significant morbidity and mortality in advanced lung cancer patients. Clinical benefit of β-hydroxy-β-methylbutyrate, arginine, and glutamine (HMB/Arg/Gln) was assessed in newly diagnosed patients. Methods
Externí odkaz:
https://doaj.org/article/a637c928abdc4896ae6ff81175749fe0
Autor:
Stuart A. McIntosh, Charlotte E. Coles, David Dodwell, Kenneth Elder, Jessica Foster, Claire Gaunt, Amanda Kirkham, Iain Lyburn, Jenna Morgan, Sangeetha Paramasivan, Sarah E. Pinder, Sarah Pirrie, Shelley Potter, Tracy Roberts, Nisha Sharma, Hilary Stobart, Elizabeth Southgate, Sian Taylor-Phillips, Matthew Wallis, Daniel Rea
Publikováno v:
Cancer Research. 83:OT3-20
Background: Mammographic screening programmes reduce breast cancer mortality, but detect many small tumours with favourable biological features which may not progress during a woman’s lifetime. Screen-detected cancers are treated with standard surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::525ea7c6aac771d32c77d748ef792bf4
https://doi.org/10.1158/1538-7445.sabcs22-ot3-20-02
https://doi.org/10.1158/1538-7445.sabcs22-ot3-20-02
Autor:
Stuart A McIntosh, Charlotte E Coles, Carmel Conefrey, David Dodwell, Kenneth Elder, Jessica Foster, Claire Gaunt, Amanda Kirkham, Iain Lyburn, Jenna Morgan, Sangeetha Paramasivan, Sarah Pinder, Sarah Pirrie, Shelley Potter, Tracy Roberts, Nisha Sharma, Hilary Stobart, Elizabeth Southgate, Sian Taylor-Phillips, Matthew Wallis, Daniel Rea
Publikováno v:
Cancer Research. 82:OT1-06
Background:. Mammographic screening programmes have been shown to reduce breast cancer mortality. However, they detect many small tumours with favourable biological features which may not progress during a woman’s lifetime. These are treated with s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ae3db58fff68f67472930a14f5b6517
https://doi.org/10.1158/1538-7445.sabcs21-ot1-06-02
https://doi.org/10.1158/1538-7445.sabcs21-ot1-06-02
Autor:
Charlotte Gaskell, Claire Gaunt, Aimee Jackson, Joyce Thompson, Lucinda Billingham, Neil Steven, Jennifer Pascoe
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer
Background Cancer cachexia causes significant morbidity and mortality in advanced lung cancer patients. Clinical benefit of β-hydroxy-β-methylbutyrate, arginine, and glutamine (HMB/Arg/Gln) was assessed in newly diagnosed patients. Methods NOURISH,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f21809a15732478b90a0e172bbe14309
https://doaj.org/article/a637c928abdc4896ae6ff81175749fe0
https://doaj.org/article/a637c928abdc4896ae6ff81175749fe0
Autor:
Zeeshaan-Ul Hasan, Ikhlaaq Ahmed, Rubeta N. Matin, Victoria Homer, John T. Lear, Ferina Ismail, Tristan Whitmarsh, Adele C. Green, Jason Thomson, Alan Milligan, Sarah Hogan, Vanessa Van-de-Velde, Liza Mitchell-Worsford, Jonathan Kentley, Claire Gaunt, Yolande Jefferson-Hulme, Sarah J. Bowden, Piers Gaunt, Keith Wheatley, Charlotte M. Proby, Catherine A. Harwood
Background The risk of cutaneous squamous cell carcinoma (cSCC) is significantly increased in organ transplant recipients (OTRs). Clearance of actinic keratoses (AKs) is generally regarded as a surrogate biomarker for cSCC prevention. OTR-cSCC chemop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fc8457bf111b747e1d049988a541c3
https://www.repository.cam.ac.uk/handle/1810/338072
https://www.repository.cam.ac.uk/handle/1810/338072
Autor:
Stuart A. McIntosh, Charlotte E. Coles, David Dodwell, Kenneth Elder, Jessica Foster, Claire Gaunt, Amanda Kirkham, Iain Lyburn, Jenna Morgan, Sarah E. Pinder, Sarah Pirrie, Shelley Potter, Tracy Roberts, Nisha Sharma, Hilary Stobart, Elizabeth Southgate, Sian Taylor-Phillips, Matthew Wallis, Daniel Rea, Sangeetha Paramasivan
Publikováno v:
Cancer Research. 83:P6-05
Background SMALL (ISRCTN 12240119) is a novel UK phase III multicentre randomised trial comparing vacuum-assisted excision (VAE) to surgery for small screen-detected breast cancers with biologically favourable characteristics. Acceptance by the clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f0913fcdbf96590f63a2c1cc7e85948
https://doi.org/10.1158/1538-7445.sabcs22-p6-05-17
https://doi.org/10.1158/1538-7445.sabcs22-p6-05-17